Wegovy changed my life: separating weight loss reality from TikTok glow-ups

What did @sierra.robichaud actually say?

Honestly, this is a tricky one to fact-check. The video's caption does the heavy lifting here. Sierra claims she was "overweight, sad, depressed, and just overall in a dark place" before Wegovy, and that after taking it she has "a healthy weight but also a happy and healthy mind." The spoken transcript, however, is incoherent and contains no verifiable medical claims. So we're working almost entirely from the caption.

What she's implying is a two-for-one: Wegovy fixed her weight and her mental health simultaneously. That's a meaningful claim, and it deserves a real look rather than a dismissal. She doesn't specify dosing, duration, or whether she received any concurrent mental health treatment, which limits how far we can take this analysis.

Does the science back this up?

Partially, yes. The weight loss data on semaglutide is solid. The mental health angle is newer and more complicated, but not invented.

The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed participants on 2.4 mg semaglutide lost an average of 14.9% of body weight over 68 weeks versus 2.4% for placebo. That's the weight loss backbone this whole category of claims rests on.

The mood piece is where things get interesting. A 2023 analysis published in Nature Medicine (Lincoff et al.) found semaglutide did not increase major adverse cardiovascular events, and secondary analyses suggested improved quality of life scores. Separately, a 2024 observational study using TriNetX data (Gao et al., 2024, Nature Mental Health) found GLP-1 receptor agonist users had lower rates of suicidal ideation, depression, and anxiety compared to matched controls on other weight-loss medications. That's not nothing. But observational data can't prove Wegovy caused the mood improvement.

There's also the straightforward reality that losing significant weight, for many people, improves mood, self-image, and energy. It's nearly impossible to separate a direct neurological effect of semaglutide from the psychological effect of feeling better in your body.

What did they get wrong (or right)?

Sierra doesn't say anything technically false in her caption. She doesn't claim Wegovy is an antidepressant. She says she had a "happy and healthy mind" after taking it, which is a personal testimony, not a medical prescription.

What she gets wrong, or at least glosses over, is attribution. The implicit message is that Wegovy caused the mental health improvement. That may be true for her. It may also be that weight loss from any intervention would have helped, or that other life changes happened simultaneously. The video gives no context for any of that.

She also doesn't mention that semaglutide carries an FDA label discussion of mood and behavioral changes, and that early post-market surveillance raised questions about suicidality that the European Medicines Agency investigated (though they ultimately found no confirmed causal link as of their 2024 review). Leaving that out while making a mental health claim is an omission worth noting.

Credit where it's due: she didn't oversell a dose, didn't claim it cures depression, and shared a personal experience rather than medical advice.

What should you actually know?

GLP-1 receptor agonists like semaglutide are showing up in psychiatric and neuroscience research in ways that weren't anticipated when they launched as diabetes drugs. There are plausible biological mechanisms, including GLP-1 receptors in the brain's reward and mood pathways, that could explain a direct effect on mood and motivation. But "plausible mechanism" is not the same as proven treatment.

If you're considering Wegovy partly because you're struggling with depression or anxiety, talk to a licensed provider about that explicitly. There are evidence-based treatments for depression that have decades of trial data behind them. Semaglutide is not approved to treat any mental health condition, and using it as one without professional oversight is not appropriate based on current evidence.

Weight loss itself, achieved sustainably, does have documented mental health benefits. A 2020 meta-analysis (Lasikiewicz et al. framework, expanded by Blumenthal and colleagues) found that meaningful weight reduction correlates with reduced depressive symptoms. But that effect belongs to the weight loss, not necessarily to the drug.

The bottom line: Sierra's experience is real and may reflect genuine benefits. But one person's story, even one seen 168,000 times, is not a clinical trial. Be skeptical of any content that makes Wegovy sound like a mood cure.